What's in Johannes Grand's pipeline?

Johannes Grand has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Johannes Grand's portfolio?

Top competitors by shared drug class: , Bausch Health, Generic (originally Hoechst AG).

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/johannes-grand.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Johannes Grand — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Johannes Grand pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Furosemide Injection	Furosemide Injection	marketed	Loop Diuretic [EPC]

Therapeutic area mix

No therapeutic area data.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

· 1 shared drug class
Bausch Health · 1 shared drug class
Generic (originally Hoechst AG) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Johannes Grand:

Cite this brief

Drug Landscape (2026). Johannes Grand — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/johannes-grand. Accessed 2026-05-16.